Cancer HealthCast: This AI Tool Could Predict a Patient’s Response to Immunotherapy
NCI cancer researcher highlights how AI is playing a pivotal role in cancer care.
Artificial intelligence is impacting two main areas of cancer research: image analysis and managing massive amounts of clinical data. The National Cancer Institute sees AI as a key capability in precision oncology.
Dr. Eytan Ruppin, chief of NCI’s Cancer Data Science Lab, recently published a study about a new AI tool researchers are implementing to foresee how a patient will respond to immunotherapy by providing an in-depth look at the clinical characteristics of the patient as well as the Tumor Mutational Burden (TMB).
Ruppin discusses the NCI/CCR Synthesis Clinical Trial expected to start this fall and shares details about how the research will impact the treatment of aggressive breast cancer.
-
Dr. Eytan Ruppin Chief, Cancer Data Science Lab NCI
-
NIST Explains What’s Next for Federal AI Standards
NIST’s Martin Stanley outlines how AI control overlays, risk frameworks and future guidance will support agencies scaling AI systems.
6m watch -
Pentagon Leaders Must Give ‘Top Cover’ for Risk-Taking, DOW Official Says
Bonnie Evangelista says acquisition reform will fail without leadership support that allows for experimentation without penalty.
3m read -
Digital GI Bill Automation Speeds VA Benefits Delivery
VA officials said Digital GI Bill upgrades have improved claims speed, enabling the department to process benefits with fewer staff.
3m read -
Who’s in Charge of AI at Every Federal Agency
New AI memos from the Trump administration prompt federal agencies to establish chief AI officers and OMB to launch a new CAIO AI Council.
7m read
